Medical technology leader Stryker has maintained its full-year organic growth and earnings targets. The company expects Q1 distortions caused by a cyber incident to normalize throughout the year.
- Organic sales growth target: 8%-9.5%
- Adjusted EPS target: $14.90-$15.10
- Cyber incident caused Q1 distortions
- CEO Kevin Lobo expects results to normalize
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.